| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/15/2004 | CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | CA2490097A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | CA2489398A1 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 01/15/2004 | CA2489071A1 Solid dispersions comprising two different polymer matrixes |
| 01/14/2004 | EP1380651A2 Recombinant fowlpox virus with intact FPV-tk-gene |
| 01/14/2004 | EP1380587A2 Oxazolo, thiazolo and selenazolo (4,5-c)-quinoline-4-amines and analogs thereof |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380303A1 Combination therapy to treat hepatitis B virus |
| 01/14/2004 | EP1380296A1 Hsp inductor |
| 01/14/2004 | EP1380290A1 Cross-beta structure pathway and its therapeutic relevance |
| 01/14/2004 | EP1379696A2 Prognostic methods for breast cancer |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379547A2 Pro-drug and use thereof as a medicament |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379530A1 Process for the selective preparation of 3-(z) propenyl-cephem compound |
| 01/14/2004 | EP1379529A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| 01/14/2004 | EP1379528A1 Pyrazolopyrimidines as therapeutic agents |
| 01/14/2004 | EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379509A1 A method for the preparation of oxazolidinones |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379280A2 Immunogenic complex |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379257A2 Prodrugs of anticancer agents employing substituted aromatic acids |
| 01/14/2004 | EP1379255A2 Substituted tetracycline compounds as antifungal agents |
| 01/14/2004 | EP1379248A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors |
| 01/14/2004 | EP1379232A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
| 01/14/2004 | EP1379231A2 Pharmacologically active strong acid solutions |
| 01/14/2004 | EP1379221A2 Pharmaceutical product with reticulated crystalline microstructure |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP1274704B1 Process for preparing 5'-acetylstavudine |
| 01/14/2004 | EP1227811B1 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 01/14/2004 | EP1019385B1 Aminoaryl oxazolidinone n-oxides |
| 01/14/2004 | EP0975761B1 Recombinant human beta interferon with enhanced solubility |
| 01/14/2004 | EP0938321B1 Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468301A Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/14/2004 | CN1468296A Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468249A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/14/2004 | CN1468247A Ethers of 7-desmethylrapamycin |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468210A Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 01/14/2004 | CN1468093A Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 01/14/2004 | CN1468091A Vaccine composition and stabilisation method |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467293A Infectious bursal disease virus (IBDV) polyprotein gene (VP2/VP4/VP3), eukaryon expressing plasmid, DNA vaccine |
| 01/14/2004 | CN1467221A Preparation and application of tubercle bacillus CFP-10, ESAT-6 and CD40L fusion bacterin |
| 01/14/2004 | CN1466996A Human SARS coronary virus receptor inhibitor |
| 01/14/2004 | CN1466994A Compositions and therapeutic use |
| 01/14/2004 | CN1466993A Recombination ªá-interferon gelatin injection |
| 01/14/2004 | CN1466987A Medicine for preventing SARS and influenza-propolis lozenge and complement synergy medicine |
| 01/14/2004 | CN1466984A Medicine for treating hepatitis |
| 01/14/2004 | CN1466981A Compound rhizome of Cyrtomium aspirin tablet |
| 01/14/2004 | CN1466974A Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same |
| 01/14/2004 | CN1466962A Method for processing aloe gelatin, aloe full-leaf gelatin and aloe skin gelatin |
| 01/14/2004 | CN1466951A Gardenoside general extracts preparation and making method and uses |
| 01/14/2004 | CN1466947A Combined medicine containing lamivudine |
| 01/14/2004 | CN1466943A Use of trans-3,4,5-trihydroxy-diphenyl and derivant for resisting hepatitis B virus |
| 01/14/2004 | CN1134486C Antiviral dendrimers |
| 01/14/2004 | CN1134449C Process for preparation of moenomycin A |
| 01/14/2004 | CN1134446C Process for preparation of 3-vinylcephem compound |
| 01/14/2004 | CN1134436C Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 01/14/2004 | CN1134421C Antifungal and its preparation method and intermediate |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134413C Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application |
| 01/14/2004 | CN1134261C Quick-acting beriberi powder |
| 01/14/2004 | CN1134258C Polymer coated tablet comprising amoxycillin and clavulanate |
| 01/14/2004 | CN1134214C Method of biological control |
| 01/13/2004 | US6677435 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-michael catalytic activity; antitumor; anticarcinogenic agents |
| 01/13/2004 | US6677429 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677348 Aryl ether substituted imidazoquinolines |
| 01/13/2004 | US6677347 Anticarcinogenic and antitumor agents; viricided, immunomodulators |
| 01/13/2004 | US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 01/13/2004 | US6677331 Having substituted imidazo(5,1-b)thiazole group at 2-position; microbiocides against beta-lactamase producing bacteria and resistant pseudomonas |
| 01/13/2004 | US6677153 Antisense antibacterial method and composition |
| 01/13/2004 | US6677133 Methods of reducing microbial resistance to drugs |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6676974 Bioactive hexane fraction from Vetiveria zizanioides |
| 01/13/2004 | US6676953 For treating fungal infections of human fingernails and toenails, and for alleviating other symptoms often associated with such fungal infections |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |